论文部分内容阅读
目的总结支气管哮喘防治新策略的实施经验和体会。方法选择2007年1月中国医科大学附属第一医院呼吸内科门诊初诊或既往确诊支气管哮喘的36例患者,吸入布地奈德/福莫特罗干粉吸入剂进行治疗,随访观察6个月,记录临床症状、按需使用缓解药、肺功能相关指标和哮喘症状及病情评估问卷评分变化情况。结果经过6个月系统治疗与随访,大部分患者观察指标均较明显改善,肺功能相关指标较治疗前有不同程度提高,哮喘控制调查(ACQ)评分均呈下降趋势,与症状缓解及缓解药物使用减少情况一致,哮喘控制测试(ACT)评分呈上升趋势。结论医生为支气管哮喘患者制定个体化治疗方案的同时帮助其学会自我管理,有助于哮喘病情的持续缓解和长期控制。
Objective To summarize the experience and experience of the new strategy of bronchial asthma prevention and control. Methods Thirty-six patients with newly diagnosed bronchial asthma or first diagnosed bronchial asthma in the First Affiliated Hospital of China Medical University were enrolled in January 2007 and inhaled budesonide / formoterol powder inhalation was followed up for 6 months. The clinical records Symptoms, on-demand use of relievers, lung function-related indicators and asthma symptoms and disease assessment questionnaire score changes. Results After 6 months of systematic treatment and follow-up, most of the patients showed significantly improved observation and the indexes of pulmonary function improved to some extent before treatment. The ACQ score showed a decreasing trend, and the symptoms were relieved and the drug Consistent with reduced use, the Asthma Control Test (ACT) score is on the rise. Conclusions Doctors can help individuals learn how to manage themselves while developing individualized treatment plans for patients with bronchial asthma, which will be helpful for the sustained relief and long-term control of asthma.